Flatiron Health vs Insilico Medicine

Side-by-side comparison of Flatiron Health and Insilico Medicine: pricing, features, API access, and community ratings.

AI comparison summary

Generating comparison…

	Flatiron Health Real answers to guide oncology's highest-stakes decisions with AI-powered real-world evidence Visit	Insilico Medicine Generative AI platform for end-to-end drug discovery, from target identification to clinical trials Visit
Category	Healthcare & biotech	Healthcare & biotech
Pricing	Enterprise	Enterprise
Starting price
Free tier
Audience	All audiences	Technical
API available
Open source
Self-hostable
Model provider	Proprietary (LLM + ML)	Insilico Medicine (proprietary LLLMs)
Founded	2012	2014
Headquarters	New York, USA	Cambridge, USA
Key strengths	·High-fidelity oncology real-world data from millions of cancer patients ·AI combined with human expertise for clinical and research insights ·Supports 2,000+ peer-reviewed publications ·Serves both life sciences and point-of-care clinical settings	·End-to-end AI-driven drug discovery pipeline (target ID to clinical trials) ·Generative chemistry and biology AI (Chemistry42, Generative Biologics) ·Large Language of Life Models (LLLMs) for biomedical research ·Validated therapeutic pipeline with programs in Phase I/II trials